About the Authors
- Sabrina Kneissl
-
* E-mail: Sabrina.Kneissl@pei.de (SK); Christian.Buchholz@pei.de (CJB)
Affiliation Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, Langen, Germany
- Tobias Abel
-
Affiliation Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, Langen, Germany
- Anke Rasbach
-
Affiliation Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, Langen, Germany
- Julia Brynza
-
Affiliation Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, Langen, Germany
- Jürgen Schneider-Schaulies
-
Affiliation Institute of Virology and Immunobiology, University of Würzburg, Würzburg, Germany
- Christian J. Buchholz
-
* E-mail: Sabrina.Kneissl@pei.de (SK); Christian.Buchholz@pei.de (CJB)
Affiliation Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, Langen, Germany
Competing Interests
SK and CJB are listed as inventors in an international Patent Cooperation Treaty/European patent application (PCT/EP2007/008384 “Pseudotyping of retroviral vectors, methods for production and use thereof for targeted gene transfer and high-throughput screening”) assigned to the Paul-Ehrlich-Institut, which includes as claims the generation of targeted lentiviral vectors. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: SK CJB. Performed the experiments: SK TA JB. Analyzed the data: SK TA AR CJB. Contributed reagents/materials/analysis tools: JS-S. Wrote the paper: SK CJB.